An injectable contraception used by women in some countries has been linked to an increased risk of a type of brain tumour. The study, published in the British Medical Journal (BMJ), found people ...

Approximately 19 million U.S. women of childbearing age reside in what are known as “contraceptive deserts” due to geographic, political, economic and social barriers to birth control. Women living in ...

Women in America and the United Kingdom are taking legal action against Pfizer and other birth control producers after a study indicated that injectable contraceptives were found to cause brain tumors ...

1 in 4 sexually active women has used injectable birth control, administered into the muscle by a clinician, but many may be unaware of its association with meningioma, the most common brain tumor in ...

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused ...

Barrier and hormonal contraception methods only temporarily prevent pregnancy. Once a person stops using these methods, the body’s natural fertility will typically resume. Sterilization methods, such ...

Kenya's reproductive health services got a major boost after receiving 450,000 doses of self-injectable contraceptives. The Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) contraceptives, ...

Guests and partners in the launch of private sector Depo Medroxy Progesterone Subcutaneous( DMPA- SC) contraceptive which is self-injected. [ Jenipher Wachie, Standard] Pharmacies will now serve as ...

As part of an update to the CDC's practice recommendations on contraception, physicians are being encouraged to counsel patients on pain associated with intrauterine device (IUD) insertion. To ...

This story originally appeared on 6abc. Pharmacies in New Jersey are now allowed to sell hormonal contraceptive birth control without a prescription. Gov. Phil Murphy signed a bill into law that ...

Between condoms and vasectomies lies a vast, undeveloped chasm of male birth control. Contraline, a device startup that released early, positive clinical data in a press release on Thursday, hopes to ...